5-149306380-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000296721.9(AFAP1L1):c.511G>A(p.Val171Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,724 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
ENST00000296721.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AFAP1L1 | NM_152406.4 | c.511G>A | p.Val171Met | missense_variant | 6/19 | ENST00000296721.9 | NP_689619.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AFAP1L1 | ENST00000296721.9 | c.511G>A | p.Val171Met | missense_variant | 6/19 | 1 | NM_152406.4 | ENSP00000296721 | P1 | |
AFAP1L1 | ENST00000515000.1 | c.511G>A | p.Val171Met | missense_variant | 6/18 | 1 | ENSP00000424427 | |||
AFAP1L1 | ENST00000455574.6 | n.609G>A | non_coding_transcript_exon_variant | 6/9 | 1 | |||||
AFAP1L1 | ENST00000522492.1 | n.635G>A | non_coding_transcript_exon_variant | 7/8 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 247822Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134046
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1460464Hom.: 0 Cov.: 30 AF XY: 0.00000551 AC XY: 4AN XY: 726340
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74390
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at